Log In
Print
BCIQ
Print
Print this Print this
 

CTP-221

  Manage Alerts
Collapse Summary General Information
Company Concert Pharmaceuticals Inc.
DescriptionDeuterated S-enantiomer of lenalidomide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today